Studying MYC in high-risk medulloblastoma
Part of Cancer clinical trials.
This study looks at tumor tissue from children and young adults with a specific type of brain tumor called medulloblastoma. The goal is to understand the tumor better and find new ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The patient must be between 0 and 20 years old.
- The patient must be diagnosed with Group 3 medulloblastoma (a specific type of brain tumor).
- Surgery must be done at the Gemelli hospital in Rome.
- Tumor tissue from surgery must be available for research.
- Informed consent (agreement) must be given by the patient or parent/guardian.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
Hear when a new Medulloblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.